Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 83 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Giấy xác nhận về việc thay đổi nội dung đăng ký doanh nghiệp
Regulatory Filings Classification · 85% confidence The document is an official disclosure filed with the State Securities Commission and Ho Chi Minh Stock Exchange titled “Công bố thông tin định kỳ” (Disclosure of Periodic Information). It notifies investors/regulators of a change in enterprise registration details and attaches the certificate confirming those changes. There are no financial statements, earnings metrics, or substantive report analysis. It is a compliance/regulatory announcement of changed corporate registration information, which falls under the general category of Regulatory Filings (RNS).
2026-05-07 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của Người nội bộ Nguyễn Thái Dương
Director's Dealing Classification · 92% confidence The document is a regulatory report filed by an insider (Member of the Board of Directors) detailing his personal transaction in the company’s shares (purchase of 267,393 shares, ownership changes, trading method, date, and legal references). This matches the definition of an insider/director dealing disclosure rather than a company share buy-back or other category. Therefore, the appropriate category is Director's Dealing (DIRS).
2026-05-06 Vietnamese
DBT: Nghị quyết, Biên bản họp ĐHĐCĐ thường niên năm tài chính 2025 và tài liệu kèm theo
AGM Information Classification · 85% confidence The document consists of the resolutions (“Nghị quyết”) and meeting minutes (“Biên bản họp”) from the company’s Annual General Meeting of shareholders for the 2025 financial year. It details the AGM agenda, voting results, and implementation clauses. This corresponds to materials generated at and about the AGM rather than a formal annual report, earnings release, or proxy statement. Hence the appropriate classification is AGM Information (AGM-R).
2026-04-29 Vietnamese
DBT: Thông báo thay đổi nhân sự
Board/Management Information Classification · 90% confidence The document is an official notice to the Vietnam Exchange and Ho Chi Minh Stock Exchange of changes in the company’s board personnel (appointment and dismissal of Board members) based on an AGM resolution. It does not present full financial statements or minutes for obtaining shareholder votes. It is clearly an announcement of senior management/board changes, which falls under Board/Management Information (MANG).
2026-04-29 Vietnamese
DBT: Báo cáo thường niên năm 2025
Annual Report Classification · 90% confidence The document is labeled “Báo cáo thường niên năm 2025” (Annual Report 2025) for Công ty Cổ phần Dược phẩm Bến Tre and contains a full table of contents covering company overview, business operations, management and board evaluations, governance, and audited financial statements. It is a comprehensive yearly report rather than an announcement or supplement, matching the Annual Report definition. FY 2025
2026-04-21 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của người nội bộ Nguyễn Khắc Hanh
Director's Dealing Classification · 95% confidence The document is a mandatory regulatory disclosure by an insider (Chairman cum Deputy CEO) detailing personal share transactions (number of shares held before and after, shares sold, transaction dates, method, value, etc.), matching the definition of a Director’s Dealing report of personal share trades by company directors/executives. This is not a corporate share buyback but an insider trading report.
2026-04-21 Vietnamese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.